Defilade Capital Management, L.P.
Source: SEC Form 13F · as of Mar 2026Defilade Capital Management, L.P. holds 10 biotech & pharma companies tracked by BioSniper, totaling $205.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$205.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for PTC THERAPEUTICS, INC. (PTCT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PTCTPTC THERAPEUTICS, INC. | 376,165 | $41.1M |
| INSMINSMED Inc | 194,909 | $31.9M |
| RVMDREVOLUTION MEDICINES, INC. | 315,972 | $30.7M |
| DNLIDenali Therapeutics Inc. | 1,359,969 | $26.1M |
| OLMAOlema Pharmaceuticals, Inc. | 1,504,536 | $22.4M |
| COGTCogent Biosciences, Inc. | 352,590 | $13.6M |
| NUVLNuvalent, Inc. | 129,950 | $13.3M |
| OCULOCULAR THERAPEUTIX, INC | 1,487,645 | $12.6M |
| ORICOric Pharmaceuticals, Inc. | 842,928 | $10.7M |
| BHVNBiohaven Ltd. | 315,944 | $2.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.